Pre-B Cell Proliferation and Lymphoblastic Leukemia/high-grade Lymphoma in E(mu)-miR155 Transgenic Mice
Overview
Authors
Affiliations
MicroRNAs (miRNAs) represent a newly discovered class of posttranscriptional regulatory noncoding small RNAs that bind to targeted mRNAs and either block their translation or initiate their degradation. miRNA profiling of hematopoietic lineages in humans and mice showed that some miRNAs are differentially expressed during hematopoietic development, suggesting a role in hematopoietic cell differentiation. In addition, recent studies suggest the involvement of miRNAs in the initiation and progression of cancer. miR155 and BIC, its host gene, have been reported to accumulate in human B cell lymphomas, especially in diffuse large B cell lymphomas, Hodgkin lymphomas, and certain types of Burkitt lymphomas. Here, we show that E(mu)-mmu-miR155 transgenic mice exhibit initially a preleukemic pre-B cell proliferation evident in spleen and bone marrow, followed by frank B cell malignancy. These findings indicate that the role of miR155 is to induce polyclonal expansion, favoring the capture of secondary genetic changes for full transformation.
Jame-Chenarboo F, Reyes J, Twells N, Ng H, Macdonald D, Hernando E Sci Adv. 2025; 11(2):eadr0277.
PMID: 39792681 PMC: 11721578. DOI: 10.1126/sciadv.adr0277.
The Role of microRNA-155 as a Biomarker in Diffuse Large B-Cell Lymphoma.
Koumpis E, Georgoulis V, Papathanasiou K, Papoudou-Bai A, Kanavaros P, Kolettas E Biomedicines. 2025; 12(12.
PMID: 39767565 PMC: 11673977. DOI: 10.3390/biomedicines12122658.
Immune checkpoints and ncRNAs: pioneering immunotherapy approaches for hematological malignancies.
Anvari S, Nikbakht M, Vaezi M, Amini-Kafiabad S, Ahmadvand M Cancer Cell Int. 2024; 24(1):410.
PMID: 39702293 PMC: 11660508. DOI: 10.1186/s12935-024-03596-8.
DGNMDA: Dual Heterogeneous Graph Neural Network Encoder for miRNA-Disease Association Prediction.
Lu D, Zhang Q, Zheng C, Li J, Yin Z Bioengineering (Basel). 2024; 11(11).
PMID: 39593792 PMC: 11591469. DOI: 10.3390/bioengineering11111132.
Non-coding RNAs as therapeutic targets in cancer and its clinical application.
Leng X, Zhang M, Xu Y, Wang J, Ding N, Yu Y J Pharm Anal. 2024; 14(7):100947.
PMID: 39149142 PMC: 11325817. DOI: 10.1016/j.jpha.2024.02.001.